Viemed Healthcare, Inc. VMD
We take great care to ensure that the data presented and summarized in this overview for VIEMED HEALTHCARE, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding VMD
View all-
Thrivent Financial For Lutherans Minneapolis, MN3.43MShares$24.2 Million0.05% of portfolio
-
Black Rock Inc. New York, NY2.91MShares$20.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.79MShares$12.7 Million0.0% of portfolio
-
Forager Capital Management, LLC Birmingham, AL1.72MShares$12.1 Million5.77% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.33MShares$9.39 Million0.05% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.3MShares$9.19 Million4.41% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.14MShares$8.05 Million3.44% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT935KShares$6.61 Million0.38% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN846KShares$5.98 Million0.4% of portfolio
-
Geode Capital Management, LLC Boston, MA765KShares$5.41 Million0.0% of portfolio
Latest Institutional Activity in VMD
Top Purchases
Top Sells
About VMD
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Insider Transactions at VMD
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Mar 14
2025
|
Timothy Smokoff Director |
SELL
Open market or private sale
|
Direct |
3,000
-3.62%
|
$21,000
$7.73 P/Share
|
|
Mar 13
2025
|
Timothy Smokoff Director |
SELL
Open market or private sale
|
Direct |
8,865
-2.5%
|
$62,055
$7.7 P/Share
|
|
Jan 29
2025
|
Michael Moore President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,948
-4.8%
|
$71,584
$8.28 P/Share
|
|
Jan 29
2025
|
Michael Moore President |
BUY
Exercise of conversion of derivative security
|
Direct |
35,791
+8.65%
|
-
|
|
Jan 29
2025
|
Michael Moore President |
SELL
Payment of exercise price or tax liability
|
Direct |
8,147
-4.41%
|
$65,176
$8.28 P/Share
|
|
Jan 29
2025
|
Casey Hoyt Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,266
-4.84%
|
$106,128
$8.28 P/Share
|
|
Jan 29
2025
|
Casey Hoyt Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
53,062
+8.65%
|
-
|
|
Jan 29
2025
|
Casey Hoyt Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,578
-4.95%
|
$108,624
$8.28 P/Share
|
|
Jan 29
2025
|
William Frazier Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
778
-1.11%
|
$6,224
$8.28 P/Share
|
|
Jan 29
2025
|
William Frazier Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,113
+2.16%
|
-
|
|
Jan 29
2025
|
William Frazier Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
693
-0.99%
|
$5,544
$8.28 P/Share
|
|
Jan 29
2025
|
Jerome Cambre Vice President of Sales |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,873
-3.12%
|
$22,984
$8.28 P/Share
|
|
Jan 29
2025
|
Jerome Cambre Vice President of Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
11,492
+5.81%
|
-
|
|
Jan 29
2025
|
Jerome Cambre Vice President of Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
2,582
-2.82%
|
$20,656
$8.28 P/Share
|
|
Jan 29
2025
|
Jeremy Trahan General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,592
-14.51%
|
$28,736
$8.28 P/Share
|
|
Jan 29
2025
|
Jeremy Trahan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
14,366
+21.39%
|
-
|
|
Jan 29
2025
|
Jeremy Trahan General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,841
-15.36%
|
$30,728
$8.28 P/Share
|
|
Jan 29
2025
|
Trae Fitzgerald Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,265
-3.79%
|
$26,120
$8.28 P/Share
|
|
Jan 29
2025
|
Trae Fitzgerald Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,060
+6.94%
|
-
|
|
Jan 29
2025
|
Trae Fitzgerald Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,962
-3.45%
|
$23,696
$8.28 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 590K shares |
|---|---|
| Open market or private purchase | 2.82K shares |
| Open market or private sale | 168K shares |
|---|---|
| Sale (or disposition) back to the issuer | 127K shares |
| Payment of exercise price or tax liability | 80.9K shares |